BALAJI, M. S.; GIRISH, M. A study of utility of delta IgG as a prognostic marker in Guillain Barre Syndrome after IV immunoglobulin treatment. International journal of health sciences, [S. l.], v. 6, n. S5, p. 4274–4287, 2022. DOI: 10.53730/ijhs.v6nS5.9555. Disponível em: https://sciencescholar.us/journal/index.php/ijhs/article/view/9555. Acesso em: 17 nov. 2024.